Brief: CERo Therapeutics Says Co Informed FDA Placed Clinical Hold On Its Investigational New Drug Application Of CER-1236

CERo Therapeutics Holdings

26/07/2024 23:35

July 26 (Reuters) - CERo Therapeutics Holdings Inc
 CERO.O :
    * CERO THERAPEUTICS: WAS INFORMED THAT FDA PLACED CLINICAL
HOLD ON
CO'S INVESTIGATIONAL NEW DRUG APPLICATION OF CER-1236
    * CERO THERAPEUTICS: CONTINUES TO BELIEVE THAT IT WILL BE
ABLE TO
INITIATE PLANNED CLINICAL TRIAL BY END OF 2024
    * CERO THERAPEUTICS- FDA SAID CLINICAL HOLD HAS BEEN PLACED
DUE TO
INSUFFICIENT DATA GIVEN FOR TWO ISSUES WITHIN PHARMACOLOGY AND
TOXICOLOGY OF CER-1236

Source text for Eikon:  ID:n0001013762-24-001702 
Further company coverage:  CERO.O 

 ((Reuters.Briefs@thomsonreuters.com;))